Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer treatment Calquence, GSK’s chronic obstructive pulmonary disorder (COPD) drug Breo Ellipta, and AbbVie’s antipsychotic medication Vraylar.
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...
Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...
A patriot and leader, Mr. Paul Mango touched the lives of many, leaving behind a tremendous legacy and an inspiring beacon for all fighting for a healthy America.
Pharmaceutical company Novartis has filed a lawsuit against the HHS over the way drugs are priced under the 340B program.
The Supreme Court unanimously upheld a law that threatens to shut down TikTok as soon as Sunday. The justices ruled free ...
Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country is healthier and stronger." ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback